Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases.
Saved in:
| Title: | Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases. |
|---|---|
| Authors: | Shengule S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Alai S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Bhandare S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Patil S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Gautam M; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Mangaonkar B; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Gupta S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Shaligram U; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India., Gairola S; Clinical Bioanalytical Department, Serum Institute of India Pvt. Ltd., Pune 411028, India. |
| Source: | Vaccines [Vaccines (Basel)] 2024 Apr 18; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines12040433 |
